To accommodate small fluid volumes, repackaging of intravenous fat emulsions (IVFEs) is frequently performed in institutions providing parenteral nutrition to neonates and smaller pediatric patients. However, some consider this an unsafe practice. Concerns for potential administration errors leading to an overdose of IVFEs are weighed against the potential for microbial contamination from the repackaging process. The clinician providing pediatric nutrition support should tailor repackaging practices to ensure patient safety and quality. This discussion aims to describe the strengths and limitations surrounding IVFE repackaging to provide guidance regarding the practice.
MellyMAMengHCSchaffnerW. Microbiol growth in lipid emulsions used in parenteral nutrition. Arch Surg. 1975;110(12):1479-1481.
9.
MellyMAMengHCSchaffnerW. Microbiol growth in lipid emulsions used in parenteral nutrition. Arch Surg. 1975;110(12):1479-1481.
10.
McKeeKTMellyMAGreeneHLSchaffnerW. Gram-negative bacillary sepsis associated with use of lipid emulsion in parenteral nutrition. Am J Dis Child. 1979;133:649-650.
11.
KimCHLewisDEKumarA. Bacterial and fungal growth in intravenous fat emulsions. Am J Hosp Pharm. 1983;40(12):2159-2161.
12.
KeammererDMayhallCGHallGOPeskoLJThomasRB. Microbial growth patterns in intravenous fat emulsions. Am J Hosp Pharm. 1983;40(10):1650-1653.
13.
JarvisWRHighsmithAK. Bacterial growth and endotoxin production in lipid emulsion. J Clin Microbiol. 1984;19(1):17-20.
14.
CrockerKSNogaRFilibeckDJKreySHMarkovicMSteffeeWP. Microbial growth comparisons of five commercial parenteral lipid emulsions. JPEN J Parenter Enteral Nutr. 1984;8(4):391-395.
15.
Avila-FigueroaCGoldmannDARichardsonDKGrayJEFerrariAFreemanJ. Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns. Pediatr Infect Dis J. 1998;17(1):10-17.
16.
JarvisWRHighsmithAKAllenJRHaleyRW. Polymicrobial bacteremia associated with lipid emulsion in a neonatal intensive care unit. Pediatr Infect Dis. 1983;2(3):203-208.
17.
FreemanJGoldmannDASmithNESidebottomDGEpsteinMFPlattR. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med. 1990;323(5):301-308.
18.
EbbertMLFarrajMHwangLT. The incidence and clinical significance of intravenous fat emulsion contamination during infusion. JPEN J Parenter Enteral Nutr. 1987;11(1):42-45.
19.
ReiterPD. Sterility of intravenous fat emulsion in plastic syringes. Am J Health Syst Pharm. 2002;59(19):1857-1859.
20.
TrisselLA. Sterility of fat emulsion in plastic syringes. Am J Health Syst Pharm. 2003;60(2):196-198.
21.
DriscollDF. Sterility of fat emulsion in plastic syringes. Am J Health Syst Pharm. 2003;60(2):197-198.
22.
ReiterPDRoblesJDowellEB. Effect of 24-hour intravenous tubing set change on the sterility of repackaged fat emulsion in neonates. Ann Pharmacother. 2004;38(10):1603-1607.
23.
CrillCMHakEBRobinsonLAHelmsRA. Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion. Am J Health Syst Pharm. 2010;67(11):914-918.
24.
YbarraJVRoseWECurtisCSSacksGS. Sterility of pediatric lipid emulsions repackaged by an automated compounding device. JPEN J Parenter Enteral Nutr. 2011;35(3):391-394.
25.
DedonatoBMBickfordLIGatesRJ. Microbial growth in neonatal intravenous fat emulsion administered over 12 versus 24 hours. J Pediatr Pharmacol Ther. 2013;18(4):298-302.
26.
O’GradyNPAlexanderMBurnsLAGuidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39(4)(suppl 1):S1-34.
SegretiJGarcia-HouchinsSGorskiLConsensus conference on prevention of central line-associated bloodstream infections: 2009. J Infus Nurs. 2011;34(2):126-133.
